Towa Pharmaceutical Co., Ltd.
4553.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥45,471,000 | ¥29,650,000 | ¥24,257,000 | ¥32,830,000 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥71,631,000 | ¥71,657,000 | ¥54,392,000 | ¥50,748,000 |
| Inventory | ¥108,287,000 | ¥101,072,000 | ¥92,927,000 | ¥72,701,000 |
| Other Curr. Assets | ¥21,917,000 | ¥15,339,000 | ¥11,414,000 | ¥10,585,000 |
| Total Curr. Assets | ¥247,306,000 | ¥217,718,000 | ¥182,990,000 | ¥166,864,000 |
| Property Plant & Equip (Net) | ¥168,423,000 | ¥153,642,000 | ¥127,004,000 | ¥100,857,000 |
| Goodwill | ¥28,115,000 | ¥32,568,000 | ¥34,613,000 | ¥44,647,000 |
| Intangibles | ¥17,727,000 | ¥18,018,000 | ¥18,331,000 | ¥9,454,000 |
| Long-Term Investments | ¥1,377,000 | ¥1,248,000 | ¥3,104,000 | ¥3,035,000 |
| Tax Assets | ¥6,037,000 | ¥5,699,000 | ¥5,303,000 | ¥5,075,000 |
| Other NC Assets | ¥1,838,000 | ¥1,760,000 | -¥1,000 | -¥2,000 |
| Total NC Assets | ¥223,517,000 | ¥212,935,000 | ¥188,354,000 | ¥163,066,000 |
| Other Assets | ¥0 | ¥5,000 | ¥3,000 | ¥5,000 |
| Total Assets | ¥470,823,000 | ¥430,653,000 | ¥371,347,000 | ¥329,935,000 |
| Liabilities | – | – | – | – |
| Payables | ¥30,041,000 | ¥26,372,000 | ¥31,284,000 | ¥17,041,000 |
| Short-Term Debt | ¥25,488,000 | ¥13,232,000 | ¥11,204,000 | ¥61,507,000 |
| Tax Payable | ¥0 | ¥7,926,000 | ¥1,190,000 | ¥4,285,000 |
| Deferred Revenue | ¥0 | ¥7,926,000 | ¥14,129,000 | ¥15,644,000 |
| Other Curr. Liab. | ¥32,410,000 | ¥24,662,000 | ¥20,722,000 | ¥16,596,000 |
| Total Curr. Liab. | ¥87,939,000 | ¥80,118,000 | ¥78,529,000 | ¥115,073,000 |
| LT Debt | ¥206,878,000 | ¥189,124,000 | ¥150,314,000 | ¥79,194,000 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥4,378,000 | ¥5,519,000 | ¥5,611,000 | ¥5,662,000 |
| Total NC Liab. | ¥211,256,000 | ¥194,643,000 | ¥155,925,000 | ¥82,694,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥13,184,000 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥299,195,000 | ¥274,761,000 | ¥234,454,000 | ¥197,767,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥128,179,000 | ¥129,078,000 |
| Common Stock | ¥4,717,000 | ¥4,717,000 | ¥4,717,000 | ¥4,717,000 |
| Retained Earnings | ¥150,502,000 | ¥134,452,000 | ¥121,232,000 | ¥122,131,000 |
| AOCI | ¥14,149,000 | ¥14,491,000 | ¥8,714,000 | ¥3,090,000 |
| Other Equity | ¥2,257,000 | ¥2,232,000 | ¥2,229,000 | ¥2,229,000 |
| Total Equity | ¥171,625,000 | ¥155,892,000 | ¥136,893,000 | ¥132,168,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥470,823,000 | ¥430,653,000 | ¥371,347,000 | ¥329,935,000 |
| Net Debt | ¥186,895,000 | ¥172,706,000 | ¥137,261,000 | ¥107,871,000 |